These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26101812)

  • 1. Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter.
    Lykke K; Töllner K; Römermann K; Feit PW; Erker T; MacAulay N; Löscher W
    Br J Pharmacol; 2015 Sep; 172(18):4469-4480. PubMed ID: 26101812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A.
    Lykke K; Töllner K; Feit PW; Erker T; MacAulay N; Löscher W
    Epilepsy Behav; 2016 Jun; 59():42-9. PubMed ID: 27088517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs.
    Hannaert P; Alvarez-Guerra M; Pirot D; Nazaret C; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):193-9. PubMed ID: 11882915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
    Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
    Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and functional characterization of the human NKCC2 isoforms.
    Carota I; Theilig F; Oppermann M; Kongsuphol P; Rosenauer A; Schreiber R; Jensen BL; Walter S; Kunzelmann K; Castrop H
    Acta Physiol (Oxf); 2010 Jul; 199(3):327-38. PubMed ID: 20146722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS pharmacology of NKCC1 inhibitors.
    Löscher W; Kaila K
    Neuropharmacology; 2022 Mar; 205():108910. PubMed ID: 34883135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B.
    Hampel P; Römermann K; MacAulay N; Löscher W
    Sci Rep; 2018 Jun; 8(1):9877. PubMed ID: 29959396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide.
    Zhao Y; Roy K; Vidossich P; Cancedda L; De Vivo M; Forbush B; Cao E
    Nat Commun; 2022 May; 13(1):2747. PubMed ID: 35585053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of Cl- transport by the renal Na(+)-K(+)-Cl- cotransporter. Identification of an intracellular locus that may form part of a high affinity Cl(-)-binding site.
    Gagnon E; Bergeron MJ; Brunet GM; Daigle ND; Simard CF; Isenring P
    J Biol Chem; 2004 Feb; 279(7):5648-54. PubMed ID: 14645215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attribution of [3H]bumetanide binding to the Na+K+Cl 'co-transporter' in rabbit renal cortical plasma membranes: a caveat.
    Griffiths NM; Simmons NL
    Q J Exp Physiol; 1987 Jul; 72(3):313-29. PubMed ID: 3628698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]bumetanide binding to membranes isolated from dog kidney outer medulla. Relationship to the Na,K,Cl co-transport system.
    Forbush B; Palfrey HC
    J Biol Chem; 1983 Oct; 258(19):11787-92. PubMed ID: 6619143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Membrane Targeting of Endogenous NKCC2 in COS7 Cells Bypasses Functional Golgi Cisternae and Complex N-Glycosylation.
    Singh R; Kursan S; Almiahoub MY; Almutairi MM; Garzón-Muvdi T; Alvarez-Leefmans FJ; Di Fulvio M
    Front Cell Dev Biol; 2016; 4():150. PubMed ID: 28101499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The loop diuretic bumetanide as a tool in physiology and pharmacology].
    Petzinger E
    Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):412-5. PubMed ID: 1425319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP-stimulated cation cotransport in avian erythrocytes: inhibition by "loop" diuretics.
    Palfrey HC; Feit PW; Greengard P
    Am J Physiol; 1980 Mar; 238(3):C139-48. PubMed ID: 6245581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Na-K-Cl cotransporters. NKCC1, NKCC2, and the HEK cell Na-L-Cl cotransporter.
    Isenring P; Jacoby SC; Payne JA; Forbush B
    J Biol Chem; 1998 May; 273(18):11295-301. PubMed ID: 9556622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na
    Zheng LF; Ji T; Guo ZH; Wang T; Xiu XL; Liu XY; Li SC; Sun L; Xue H; Zhang Y; Zhu JX
    Eur J Pharmacol; 2020 Aug; 880():173162. PubMed ID: 32423868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotransport of water by Na⁺-K⁺-2Cl⁻ cotransporters expressed in Xenopus oocytes: NKCC1 versus NKCC2.
    Zeuthen T; Macaulay N
    J Physiol; 2012 Mar; 590(5):1139-54. PubMed ID: 22250214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the renal Na+-K+-2Cl- cotransporter is reduced by mutagenesis of N-glycosylation sites: role for protein surface charge in Cl- transport.
    Paredes A; Plata C; Rivera M; Moreno E; Vázquez N; Muñoz-Clares R; Hebert SC; Gamba G
    Am J Physiol Renal Physiol; 2006 May; 290(5):F1094-102. PubMed ID: 16291577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site.
    Migliati E; Meurice N; DuBois P; Fang JS; Somasekharan S; Beckett E; Flynn G; Yool AJ
    Mol Pharmacol; 2009 Jul; 76(1):105-12. PubMed ID: 19403703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
    Welzel B; Schmidt R; Kirchhoff L; Gramer M; Löscher W
    Epilepsy Behav; 2023 Feb; 139():109057. PubMed ID: 36586153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.